These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9298348)

  • 1. Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.
    Lein M; Brux B; Jung K; Henke W; Koenig F; Stephan C; Schnorr D; Loening SA
    Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):591-5. PubMed ID: 9298348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy.
    Richardson TD; Wojno KJ; Liang LW; Giacherio DA; England BG; Henricks WH; Schork A; Oesterling JE
    Urology; 1996 Dec; 48(6A Suppl):40-4. PubMed ID: 8973698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
    Gregorakis AK; Malovrouvas D; Stefanakis S; Petraki K; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):196-201. PubMed ID: 15936010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy--a critical assessment.
    Brändle E; Hautmann O; Bachem M; Kleinschmidt K; Gottfried HW; Grünert A; Hautmann RE
    Urology; 1999 Apr; 53(4):722-30. PubMed ID: 10197847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy.
    Stephan C; Jung K; Brux B; Lein M; Sinha P; Schnorr D; Loening SA
    Clin Chem Lab Med; 2000 Apr; 38(4):309-11. PubMed ID: 10928650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
    Gregorakis AK; Stefanakis S; Malovrouvas D; Petraki K; Gourgiotis D; Scorilas A
    Prostate; 2008 May; 68(7):759-65. PubMed ID: 18213630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation.
    Stephan C; Jung K; Brux B; Lein M; Sinha P; Schnorr D; Loening SA
    Urology; 2000 Apr; 55(4):560-3. PubMed ID: 10736503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological half-life of prostate-specific antigen after radical prostatectomy.
    van Straalen JP; Bossens MM; de Reijke TM; Sanders GT
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):53-5. PubMed ID: 7516193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen.
    Semjonow A; Hamm M; Rathert P
    World J Urol; 1993; 11(4):218-20. PubMed ID: 7508787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
    Sengupta S; Christensen CM; Zincke H; Slezak JM; Leibovich BC; Bergstralh EJ; Myers RP; Blute ML
    J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.
    Doherty AP; Bower M; Smith GL; Miano R; Mannion EM; Mitchell H; Christmas TJ
    Br J Cancer; 2000 Dec; 83(11):1432-6. PubMed ID: 11076649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is radical prostatectomy a suitable model for determination of PSA half-life?].
    Brändle E; Gottfried HW; Maier S; Flohr P; Steinbach G; Hautmann RE
    Urologe A; 1995 Sep; 34(5):419-23. PubMed ID: 7483161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy.
    Wojno KJ; Vashi AR; Schellhammer PF; Wright GL; Montie JE
    Urology; 1998 Sep; 52(3):474-8. PubMed ID: 9730464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of free and total serum PSA after prostatic surgery.
    Ravery V; Meulemans A; Boccon-Gibod L
    Eur Urol; 1998; 33(3):251-4. PubMed ID: 9555548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical retropubic prostatectomy in immunosuppressed transplant recipients.
    Thompson RH; Leibovich BC; Karnes RJ; Bergstralh EJ; Blute ML
    J Urol; 2008 Apr; 179(4):1349-52; discussion 1352-3. PubMed ID: 18289598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
    Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Huland E; Scardino PT; Kattan MW; Huland H
    J Urol; 2002 Mar; 167(3):1306-9. PubMed ID: 11832719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer.
    Haab F; Boccon-Gibod L; Delmas V; Boccon-Gibod L; Toublanc M
    Br J Urol; 1994 Nov; 74(5):626-9. PubMed ID: 7530127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.